Medicine guide

Irinotecan Accord 300 mg/15 ml

As listed in the register: Irinotecan Accord 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung

300 mg/15 ml ·

  • Prescription only
  • Cancer treatments and immune-system medicines
Made by
Accord Healthcare AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Zytostatikum

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byAccord Healthcare AG
Active substanceIrinotecani hydrochloridum trihydricum
Used inCancer treatments and immune-system medicines
Strength300 mg/15 ml
ClassificationL01CE02 · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)Abgabekategorie A
Name in the registerIrinotecan Accord 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung
Packs1 Durchstechflasche(n)
Zulassungsnummer66766
Dosisstärke3

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.